These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Clinical spectrum and long-term follow-up of 14 cases with G6PC3 mutations from the French Severe Congenital Neutropenia Registry. Desplantes C; Fremond ML; Beaupain B; Harousseau JL; Buzyn A; Pellier I; Roques G; Morville P; Paillard C; Bruneau J; Pinson L; Jeziorski E; Vannier JP; Picard C; Bellanger F; Romero N; de Pontual L; Lapillonne H; Lutz P; Chantelot CB; Donadieu J Orphanet J Rare Dis; 2014 Dec; 9():183. PubMed ID: 25491320 [TBL] [Abstract][Full Text] [Related]
25. Different pattern of gene mutations in Iranian patients with severe congenital neutropenia (including 2 new mutations). Alizadeh Z; Fazlollahi MR; Houshmand M; Maddah M; Chavoshzadeh Z; Hamidieh AA; Shamsian BS; Eshghi P; Bolandghamat Pour S; Sadaaie Jahromi H; Mansouri M; Movahedi M; Nayebpour M; Pourpak Z; Moin M Iran J Allergy Asthma Immunol; 2013 Mar; 12(1):86-92. PubMed ID: 23454784 [TBL] [Abstract][Full Text] [Related]
26. Further delineation of the phenotype of severe congenital neutropenia type 4 due to mutations in G6PC3. Banka S; Chervinsky E; Newman WG; Crow YJ; Yeganeh S; Yacobovich J; Donnai D; Shalev S Eur J Hum Genet; 2011 Jan; 19(1):18-22. PubMed ID: 20717171 [TBL] [Abstract][Full Text] [Related]
27. Amyloidosis in a Patient With Congenital Neutropenia Because of G6PC3 Deficiency. Yildirmak ZY; Ozcelik G; Ozagari AA; Genc DB; Onay H J Pediatr Hematol Oncol; 2022 Mar; 44(2):e431-e433. PubMed ID: 34224517 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia. Xia J; Bolyard AA; Rodger E; Stein S; Aprikyan AA; Dale DC; Link DC Br J Haematol; 2009 Nov; 147(4):535-42. PubMed ID: 19775295 [TBL] [Abstract][Full Text] [Related]
29. Sea-blue histiocytes in the bone marrow of a boy with severe congenital neutropenia associated with G6PC3 mutation. Tavil B; Cetin M; Gumruk F Br J Haematol; 2014 May; 165(4):426. PubMed ID: 24446813 [No Abstract] [Full Text] [Related]
30. A Severe Congenital Neutropenia Type 4 Case (G6PC3 Mutation) Presented With Large Platelets in the Peripheral Smear. Kaymak Cihan M; Bolat F; Onay H; Sari A; Ünver Korğali E; Aslan Ş; Cura C; İçağasioğlu D J Pediatr Hematol Oncol; 2016 May; 38(4):324-8. PubMed ID: 26808373 [TBL] [Abstract][Full Text] [Related]
31. Testicular failure in a patient with G6PC3 deficiency. Yeshayahu Y; Asaf R; Dubnov-Raz G; Schiby G; Simon AJ; Lev A; Somech R Pediatr Res; 2014 Aug; 76(2):197-201. PubMed ID: 24796372 [TBL] [Abstract][Full Text] [Related]
32. Variability of bone marrow morphology in G6PC3 mutations: is there a genotype-phenotype correlation or age-dependent relationship? Banka S; Wynn R; Newman WG Am J Hematol; 2011 Feb; 86(2):235-7. PubMed ID: 21264919 [No Abstract] [Full Text] [Related]
33. Phenotypic heterogeneity and evidence of a founder effect associated with G6PC3 mutations in patients with severe congenital neutropenia. Smith BN; Evans C; Ali A; Ancliff PJ; Hayee B; Segal AW; Hall G; Kaya Z; Shakoori AR; Linch DC; Gale RE Br J Haematol; 2012 Jul; 158(1):146-9. PubMed ID: 22469094 [No Abstract] [Full Text] [Related]
34. Severe Congenital Neutropenia Type 4: A Rare Disease Harboring a G6pc3 Gene Pathogenic Variant Particular to the Mexican Population. López-Rodríguez L; Svyryd Y; Benítez-Alonso EO; Rivero-García P; Luna-Muñoz L; Mutchinick OM Rev Invest Clin; 2022; 74(6):328-339. PubMed ID: 36546889 [TBL] [Abstract][Full Text] [Related]
35. Metabolic abnormalities in G6PC3-deficient human neutrophils result in severe functional defects. McKinney C; Ellison M; Briones NJ; Baroffio A; Murphy J; Tran AD; Reisz JA; D'Alessandro A; Ambruso DR Blood Adv; 2020 Dec; 4(23):5888-5901. PubMed ID: 33259599 [TBL] [Abstract][Full Text] [Related]
36. G6PC3 mutations are associated with a major defect of glycosylation: a novel mechanism for neutrophil dysfunction. Hayee B; Antonopoulos A; Murphy EJ; Rahman FZ; Sewell G; Smith BN; McCartney S; Furman M; Hall G; Bloom SL; Haslam SM; Morris HR; Boztug K; Klein C; Winchester B; Pick E; Linch DC; Gale RE; Smith AM; Dell A; Segal AW Glycobiology; 2011 Jul; 21(7):914-24. PubMed ID: 21385794 [TBL] [Abstract][Full Text] [Related]
37. DBS are suitable for 1,5-anhydroglucitol monitoring in GSD1b and G6PC3-deficient patients taking SGLT2 inhibitors to treat neutropenia. Dewulf JP; Chevalier N; Marie S; Veiga-da-Cunha M Mol Genet Metab; 2023 Nov; 140(3):107712. PubMed ID: 38353183 [TBL] [Abstract][Full Text] [Related]
38. Successful use of empagliflozin to treat neutropenia in two G6PC3-deficient children: Impact of a mutation in SGLT5. Boulanger C; Stephenne X; Diederich J; Mounkoro P; Chevalier N; Ferster A; Van Schaftingen E; Veiga-da-Cunha M J Inherit Metab Dis; 2022 Jul; 45(4):759-768. PubMed ID: 35506446 [TBL] [Abstract][Full Text] [Related]
39. A novel homozygous mutation in G6PC3 presenting as cyclic neutropenia and severe congenital neutropenia in the same family. Alangari AA; Alsultan A; Osman ME; Anazi S; Alkuraya FS J Clin Immunol; 2013 Nov; 33(8):1403-6. PubMed ID: 24105461 [TBL] [Abstract][Full Text] [Related]
40. A Novel Mutation in G6PC3 Gene Associated Non-syndromic Severe Congenital Neutropenia. Khera S; Pramanik SK; Patnaik SK Indian Pediatr; 2020 Jun; 57(6):574-575. PubMed ID: 32562405 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]